<DOC>
	<DOC>NCT00433771</DOC>
	<brief_summary>The overall objective of this study is to assess the functionality of the WallFlex™ Biliary Fully-covered stent as a palliative treatment for malignant bile duct obstruction.</brief_summary>
	<brief_title>A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Cholestasis, Extrahepatic</mesh_term>
	<criteria>Age 18 or older Clinical symptoms of biliary obstruction Inoperable extrahepatic biliary obstruction by any malignant process Willing and able to comply with the study procedures and provide written informed consent to participate in the study. Participation in an Investigational Study within 90 days prior to date of patient consent Strictures that cannot be dilated enough to pass the delivery system Perforation of any duct within the biliary tree Presence of a metal biliary stent Presence of any esophageal or duodenal stent Patients for whom endoscopic procedures are contraindicated Patients with known sensitivity to any components of the stent or delivery system Patients with active hepatitis or intrahepatic metastases that extensively involves both lobes of the liver Patients with an anticipated life expectancy of &lt; 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Malignant</keyword>
	<keyword>Cholestasis, Extrahepatic</keyword>
	<keyword>Biliary obstruction</keyword>
</DOC>